Pfizer (NYSE: PFE) director receives deferred phantom stock grant

Rhea-AI Filing Summary

Buckley Mortimer J reported acquisition or exercise transactions in this Form 4 filing.

Pfizer Inc. director Mortimer J. Buckley reported a compensation-related grant of 1,543.845 Phantom Stock Units tied to Pfizer common stock. The grant is priced at $24.29 per unit and represents deferred director compensation, including dividend equivalents.

According to the disclosure, these units will be settled in cash or common stock, at the director’s election, following his retirement from the Board of Directors. After this grant, Buckley now holds a total of 26,335.128 Phantom Stock Units directly. This filing reflects non‑market, derivative-based compensation rather than an open‑market share purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Buckley Mortimer J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	1,543.845	$24.29	$37K

Holdings After Transaction: Phantom Stock Units — 26,335.128 shares (Direct)

Footnotes (2)

1. F1. Each unit represents one phantom share of common stock.
2. F2. These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Key Figures

Phantom Stock Units granted: 1,543.845 units Grant price per unit: $24.29 per unit Total Phantom Stock Units after grant: 26,335.128 units +2 more

5 metrics

Phantom Stock Units granted 1,543.845 units Deferred director compensation grant

Grant price per unit $24.29 per unit Phantom Stock Units tied to common stock value

Total Phantom Stock Units after grant 26,335.128 units Holdings following reported transaction

Underlying common stock 1,543.845 shares Common stock equivalent for this grant

Exercise/Conversion price $0.00 Phantom units settled later in cash or stock

Key Terms

Phantom Stock Units, deferred director's compensation, dividend equivalents, settled in cash or common stock

4 terms

Phantom Stock Units financial

"Each unit represents one phantom share of common stock."

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

deferred director's compensation financial

"These units represent deferred director's compensation including dividend equivalents."

dividend equivalents financial

"Deferred compensation includes dividend equivalents thereon for the units."

Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.

settled in cash or common stock financial

"Units are settled in cash or common stock at the director's election."

FAQ

What insider transaction did Pfizer (PFE) director Mortimer J. Buckley report?

Mortimer J. Buckley reported receiving 1,543.845 Phantom Stock Units. The units are a form of deferred director compensation linked to Pfizer common stock, granted at $24.29 per unit, and increase his total Phantom Stock Unit holdings to 26,335.128 units held directly.

Are Mortimer J. Buckley’s reported Phantom Stock Units in PFE an open-market purchase?

No, the Phantom Stock Units represent a compensation grant, not an open-market trade. They are deferred director compensation, including dividend equivalents, that will be settled in cash or Pfizer common stock at Buckley’s election after he retires from the Board of Directors.

How many Pfizer-related Phantom Stock Units does Mortimer J. Buckley hold after this Form 4?

After the grant, Buckley holds 26,335.128 Phantom Stock Units. This total includes the newly awarded 1,543.845 units and reflects his direct holdings in these cash- or stock-settled phantom shares linked to Pfizer common stock as part of director compensation.

When will Mortimer J. Buckley’s Pfizer Phantom Stock Units be settled?

The Phantom Stock Units will be settled after Buckley retires from Pfizer’s Board. At that time, he can elect settlement in cash or in Pfizer common stock. Until then, they function as deferred director compensation, accruing dividend equivalents over time.

What does each Pfizer Phantom Stock Unit reported by Mortimer J. Buckley represent?

Each Phantom Stock Unit represents one phantom share of Pfizer common stock. These units track the value of Pfizer shares and include dividend equivalents, but they are not actual shares until settled later in cash or stock, following Buckley’s retirement from the Board.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/30/2026 - 03:19 PM Accepted by SEC EDGAR 06/30/2026 - 03:18 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Buckley Mortimer J

(Last) (First) (Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK NEW YORK 10001-2192

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units	(1)	06/26/2026		A		1,543.845		(2)	(2)	Common Stock	1,543.845	$24.29	26,335.128	D

Explanation of Responses:

1. Each unit represents one phantom share of common stock.

2. These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

	/s/ Shanice A. Reid, by power of atty., for Mortimer J. Buckley	06/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)